We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Cognitive Impairment Associated with Schizophrenia: Pathophysiology, Diagnosis, and Emerging Treatments
Philip D. Harvey, PhD
Martin Strassnig, MD
Understanding CIAS: What Does Current Literature Say About the Etiology and Pathophysiology of CIAS?
Glycine's Role in Driving the Cognitive Symptoms of CIAS
CIAS Effects on Patients and Caregivers: What Is the Personal and Economic Burden Caused by CIAS?
Unraveling the Overlapping Negative and Cognitive Symptoms in Schizophrenia
Tools of the Trade: Measurement-Based Care for CIAS
Challenges of Integrating Cognitive Remediation in CIAS
Limitations of the Current Therapeutics Used to Manage CIAS
Staying Current: What Do Recent Clinical Trial Data Say About the New and Emerging Treatment Options for CIAS?
Integration Is the Key to Success: How Will the New SCZ Therapies Fit Into Clinical Treatment Paradigms?
Not All Therapy Needs to Be Swallowed or Injected: The Future of Digital Therapeutics to Alleviate the Negative Symptoms of Schizophrenia
Expanding Screening, Improving Treatment Acceptance, and Optimizing Outcomes for Patients with Moderate to Severe Alcohol Use Disorder (AUD)
Annie Levesque, MD, MSc
Ethan A. Cowan, MD
Multiple Sclerosis: Using S1P Receptor Modulators to Slow Disease Progression
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
Bianca Weinstock-Guttman, MD
Missed Opportunities in Multiple Sclerosis Care: Increasing HCP Awareness of Early Diagnostic Delays
What Do Clinicians Need To Know? Utilizing Clinically Validated Diagnostic Tools to Diagnose MS Earlier
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education